Venezuelan Antitrust Authorities Sentenced Against Exclusionary Practices Between Pharmaceutical Companies Dollder & Whyeth Case

Article by Karen Incera

Last December 26, 2006, Procompetencia (the antitrust Venezuelan Authority) dictated the SPPLC/0076-06 Resolution, in which the Venezuelan pharmaceutical company Wyeth Laboratory was sanctioned to pay approximately an equivalent amount of USD 185,000 fine by the commission of restrictive exclusionary practices forbidden in the Law with the intention of impeding the entrance or presence of a competitor product in the national market.

The fact that promoted the complaint was a cease and desist letter sent by Wyeth, when it realized the eventual launch of the Dollder’s antidepressive product IDOXEN®¹ (Venlafaxine Clorhidrate) for the supposed commission of restrictive practices against the free competence, among others.